ESC 365 - Definition and prognosis of mitral regurgitation in transthyretin amyloid cardiomyopathy: an international multicentre cohort study

Open Access

Definition and prognosis of mitral regurgitation in transthyretin amyloid cardiomyopathy: an international multicentre cohort study

Session: Advances in Science in imaging in valvular heart disease

Topic: Valvular Heart Disease

Speaker: Doctor L. Hauptmann (Vienna, AT)

Event: EACVI 2025

Congress Presentation

Add to my library

About the speaker

Doctor Laurenz Hauptmann

Medical University of Vienna, Vienna (Austria)

2 presentations

0 follower

4 more presentations in this session

Physiologist-led triaging of trans-thoracic echocardiogram requests for infective endocarditis

Speaker: Mr D. Cusack (Edinburgh, GB)

Real-world performance of an automated echocardiography-based machine learning model for multiparametric mitral regurgitation severity assessment

Speaker: Professor F. Asch (Washington, DC, US)

Epidemiology, management and in-hospital outcomes of patients with mixed and multiple valvular heart disease: the international EACVI-MMVD Study

Speaker: Doctor T. Pezel (Paris, FR)

New perspectives in valvular heart disease

Speaker: Professor P. Pellikka (Rochester, US)

Access the full session

Advances in Science in imaging in valvular heart disease

Speakers: Doctor L. Hauptmann, Mr D. Cusack, Professor F. Asch, Doctor T. Pezel, Professor P. Pellikka

About the event

EACVI 2025

11 December - 13 December 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources